Abstract
Ambulatory monitoring with a Holter and event recorder has been a traditional mode of detecting paroxysmal episodes of palpitations, dizziness, or syncope thought to be caused by supraventricular and ventricular arrhythmias. Over the last decade or so, atrial fibrillation (AF) has become an increasingly important indication for ambulatory monitoring to assess the burden of the arrhythmia as well as to determine the efficacy of pharmacological and nonpharmacological therapies. In this chapter remote monitoring of patients with pacemakers and defibrillators, as well as novel methods such as ECG Apps, iPhone, and IWatch for arrhythmia detection are discussed.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Holter NJ. New method for heart studies: continuous electrocardiography of active subjects over long periods is now practical. Science. 1961;134:1214–20.
Buckles D, Aguel F, Brockman R, et al. Advances in ambulatory monitoring: regulatory considerations. J Electrocardiol. 2004;37(suppl):65–7.
Zimetbaum PJ, Josephson ME. The evolving role of ambulatory arrhythmia monitoring in general clinical practice. Ann Intern Med. 1999;130:848–56.
Vasamreddy CR, Dalal D, Dong J, et al. Symptomatic and asymptomatic atrial fibrillation in patients undergoing radiofrequency catheter ablation. J Cardiovasc Electrophysiol. 2006;17:134–9.
Hauser TH, Pinto DS, Josephson ME, Zimetbaum P. Safety and feasibility of a clinical pathway for the outpatient initiation of antiarrhythmic medications in patients with atrial fibrillation or atrial flutter. Am J Cardiol. 2003;91:1437–41.
Douen A, Pageau N, Medic S. Usefulness of cardiovascular investigation in stroke management: clinical relevance and economic implications. Stroke. 2007;38:1956–8.
Liao J, Khalid Z, Scallan C, Morillo C, O’Donnell M. Non-invasive cardiac monitoring for detecting of paroxysmal atrial fibrillation or flutter after acute ischemic stroke: a systematic review. Stroke. 2007;38:2935–40.
Saxon LA, Hayes DL, Gilliam FR, et al. Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: the ALTITUDE survival study. Circulation. 2010;122:2359–67.
Varma N, Piccini JP, Snell J, et al. The relationship between level of adherence to automatic wireless remote monitoring and survival in pacemaker and defibrillator patients. J Am Coll Cardiol. 2015;65:2601–10.
Akar JG, Bao H, Jones PW, et al. Use of remote monitoring is associated with lower risk of adverse outcomes among patients with implanted cardiac defibrillators. Circ Arrhythm Electrophysiol. 2015;8:1173–80.
Al-Khatib SM, Piccini JP, Knight D, et al. Remote monitoring of implantable cardioverter defibrillators versus quarterly device interrogations in clinic: results from a randomized pilot clinical trial. J Cardiovasc Electrophysiol. 2010;21:545–50.
Varma N, Epstein AE, Irimpen A, et al. Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial. Circulation. 2010;122:325–32.
Crossley GH, Boyle A, Vitense H, et al. The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) trial: the value of wireless remote monitoring with automatic clinician alerts. J Am Coll Cardiol. 2011;57:1181–9.
Landolina M, Perego GB, Lunati M, et al. Remote monitoring reduces healthcare use and improves quality of care in heart failure patients with implantable defibrillators: the Evolution of Management Strategies of Heart Failure Patients With Implantable Defibrillators (EVOLVO) study. Circulation. 2012;125:2985–92.
Mabo P, Defaye P, Sadoul N, et al. Remote follow-up of patients implanted with an ICD: the prospective randomized Evatel study (abstr). Heart Rhythm. 2012;9(Suppl):S226–7.
Perl S, Stiegler P, Rotman B, et al. Socio-economic effects and cost saving potential of remote patient monitoring (SAVE-HM trial). Int J Cardiol. 2013;169:402–7.
Boriani G, Da Costa A, Ricci RP, et al. The MOnitoring Resynchronization dEvices and CARdiac patiEnts (MORE-CARE) randomized controlled trial: phase 1 results on dynamics of early intervention with remote monitoring. J Med Internet Res. 2013;15:e167.
Guedon-Moreau L, Lacroix D, Sadoul N, et al. A randomized study of remote follow-up of implantable cardioverter defibrillators: safety and efficacy report of the ECOST trial. Eur Heart J. 2013;34:605–14.
Hindricks G, Taborsky M, Glikson M, et al. Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial. Lancet. 2014;384:583–90.
Parthiban N, Esterman A, Mahajan R, et al. Remote monitoring of implantable cardioverter-defibrillators: a systematic review and meta-analysis of clinical outcomes. J Am Coll Cardiol. 2015;65:2591–600.
Apple Heart Study Identifies AFib in Small Group of Apple Watch Wearers. https://www.acc.org/latest-in-cardiology/articles/2019/03/08/15/32/sat-9am-apple-heart-study-acc-2019.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Gomes, J.A. (2020). Remote Heart Rhythm Monitoring. In: Heart Rhythm Disorders. Springer, Cham. https://doi.org/10.1007/978-3-030-45066-3_35
Download citation
DOI: https://doi.org/10.1007/978-3-030-45066-3_35
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-45065-6
Online ISBN: 978-3-030-45066-3
eBook Packages: MedicineMedicine (R0)